Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility. / Guigas, B; de Leeuw van Weenen, J E; van Leeuwen, N; Simonis-Bik, A M; van Haeften, T W; Nijpels, G; Houwing-Duistermaat, J J; Beekman, M; Deelen, J; Havekes, L M; Penninx, B W J H; Vogelzangs, N; van 't Riet, E; Dehghan, A; Hofman, A; Witteman, J C; Uitterlinden, A G; Grarup, Niels; Jørgensen, Torben; Witte, D R; Lauritzen, T; Hansen, Torben; Pedersen, O; Hottenga, J; Romijn, J A; Diamant, M; Kramer, M H H; Heine, R J; Willemsen, G; Dekker, J M; Eekhoff, E M; Pijl, H; de Geus, E J; Slagboom, P E; 't Hart, L M.

In: Diabetic Medicine, Vol. 31, No. 8, 08.2014, p. 1001-8.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Guigas, B, de Leeuw van Weenen, JE, van Leeuwen, N, Simonis-Bik, AM, van Haeften, TW, Nijpels, G, Houwing-Duistermaat, JJ, Beekman, M, Deelen, J, Havekes, LM, Penninx, BWJH, Vogelzangs, N, van 't Riet, E, Dehghan, A, Hofman, A, Witteman, JC, Uitterlinden, AG, Grarup, N, Jørgensen, T, Witte, DR, Lauritzen, T, Hansen, T, Pedersen, O, Hottenga, J, Romijn, JA, Diamant, M, Kramer, MHH, Heine, RJ, Willemsen, G, Dekker, JM, Eekhoff, EM, Pijl, H, de Geus, EJ, Slagboom, PE & 't Hart, LM 2014, 'Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility', Diabetic Medicine, vol. 31, no. 8, pp. 1001-8. https://doi.org/10.1111/dme.12464

APA

Guigas, B., de Leeuw van Weenen, J. E., van Leeuwen, N., Simonis-Bik, A. M., van Haeften, T. W., Nijpels, G., Houwing-Duistermaat, J. J., Beekman, M., Deelen, J., Havekes, L. M., Penninx, B. W. J. H., Vogelzangs, N., van 't Riet, E., Dehghan, A., Hofman, A., Witteman, J. C., Uitterlinden, A. G., Grarup, N., Jørgensen, T., ... 't Hart, L. M. (2014). Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility. Diabetic Medicine, 31(8), 1001-8. https://doi.org/10.1111/dme.12464

Vancouver

Guigas B, de Leeuw van Weenen JE, van Leeuwen N, Simonis-Bik AM, van Haeften TW, Nijpels G et al. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility. Diabetic Medicine. 2014 Aug;31(8):1001-8. https://doi.org/10.1111/dme.12464

Author

Guigas, B ; de Leeuw van Weenen, J E ; van Leeuwen, N ; Simonis-Bik, A M ; van Haeften, T W ; Nijpels, G ; Houwing-Duistermaat, J J ; Beekman, M ; Deelen, J ; Havekes, L M ; Penninx, B W J H ; Vogelzangs, N ; van 't Riet, E ; Dehghan, A ; Hofman, A ; Witteman, J C ; Uitterlinden, A G ; Grarup, Niels ; Jørgensen, Torben ; Witte, D R ; Lauritzen, T ; Hansen, Torben ; Pedersen, O ; Hottenga, J ; Romijn, J A ; Diamant, M ; Kramer, M H H ; Heine, R J ; Willemsen, G ; Dekker, J M ; Eekhoff, E M ; Pijl, H ; de Geus, E J ; Slagboom, P E ; 't Hart, L M. / Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility. In: Diabetic Medicine. 2014 ; Vol. 31, No. 8. pp. 1001-8.

Bibtex

@article{a34f1a7ce1694ea8b6da103e9c727da3,
title = "Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility",
abstract = "AIMS: Modulation of dopamine receptor D2 (DRD2) activity affects insulin secretion in both rodents and isolated pancreatic β-cells. We hypothesized that single nucleotide polymorphisms in the DRD2/ANKK1 locus may affect susceptibility to Type 2 diabetes in humans.METHODS: Four potentially functional variants in the coding region of the DRD2/ANKK1 locus (rs1079597, rs6275, rs6277, rs1800497) were genotyped and analysed for Type 2 diabetes susceptibility in up to 25 000 people (8148 with Type 2 diabetes and 17687 control subjects) from two large independent Dutch cohorts and one Danish cohort. In addition, 340 Dutch subjects underwent a 2-h hyperglycaemic clamp to investigate insulin secretion. Since sexual dimorphic associations related to DRD2 polymorphisms have been previously reported, we also performed a gender-stratified analysis.RESULTS: rs1800497 at the DRD2/ANKK1 locus was associated with a significantly increased risk for Type 2 diabetes in women (odds ratio 1.14 (1.06-1.23); P = 4.1*10(-4) ) but not in men (odds ratio 1.00 (95% CI 0.93-1.07); P = 0.92) or the combined group. Although rs1800497 was not associated with insulin secretion, we did find another single nucleotide polymorphism in this locus, rs6275, to be associated with increased first-phase glucose-stimulated insulin secretion in women (P = 5.5*10(-4) ) but again not in men (P = 0.34).CONCLUSION: The present data identify DRD2/ANKK1 as a potential sex-specific Type 2 diabetes susceptibility gene.",
author = "B Guigas and {de Leeuw van Weenen}, {J E} and {van Leeuwen}, N and Simonis-Bik, {A M} and {van Haeften}, {T W} and G Nijpels and Houwing-Duistermaat, {J J} and M Beekman and J Deelen and Havekes, {L M} and Penninx, {B W J H} and N Vogelzangs and {van 't Riet}, E and A Dehghan and A Hofman and Witteman, {J C} and Uitterlinden, {A G} and Niels Grarup and Torben J{\o}rgensen and Witte, {D R} and T Lauritzen and Torben Hansen and O Pedersen and J Hottenga and Romijn, {J A} and M Diamant and Kramer, {M H H} and Heine, {R J} and G Willemsen and Dekker, {J M} and Eekhoff, {E M} and H Pijl and {de Geus}, {E J} and Slagboom, {P E} and {'t Hart}, {L M}",
note = "{\textcopyright} 2014 The Authors. Diabetic Medicine {\textcopyright} 2014 Diabetes UK.",
year = "2014",
month = aug,
doi = "10.1111/dme.12464",
language = "English",
volume = "31",
pages = "1001--8",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility

AU - Guigas, B

AU - de Leeuw van Weenen, J E

AU - van Leeuwen, N

AU - Simonis-Bik, A M

AU - van Haeften, T W

AU - Nijpels, G

AU - Houwing-Duistermaat, J J

AU - Beekman, M

AU - Deelen, J

AU - Havekes, L M

AU - Penninx, B W J H

AU - Vogelzangs, N

AU - van 't Riet, E

AU - Dehghan, A

AU - Hofman, A

AU - Witteman, J C

AU - Uitterlinden, A G

AU - Grarup, Niels

AU - Jørgensen, Torben

AU - Witte, D R

AU - Lauritzen, T

AU - Hansen, Torben

AU - Pedersen, O

AU - Hottenga, J

AU - Romijn, J A

AU - Diamant, M

AU - Kramer, M H H

AU - Heine, R J

AU - Willemsen, G

AU - Dekker, J M

AU - Eekhoff, E M

AU - Pijl, H

AU - de Geus, E J

AU - Slagboom, P E

AU - 't Hart, L M

N1 - © 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

PY - 2014/8

Y1 - 2014/8

N2 - AIMS: Modulation of dopamine receptor D2 (DRD2) activity affects insulin secretion in both rodents and isolated pancreatic β-cells. We hypothesized that single nucleotide polymorphisms in the DRD2/ANKK1 locus may affect susceptibility to Type 2 diabetes in humans.METHODS: Four potentially functional variants in the coding region of the DRD2/ANKK1 locus (rs1079597, rs6275, rs6277, rs1800497) were genotyped and analysed for Type 2 diabetes susceptibility in up to 25 000 people (8148 with Type 2 diabetes and 17687 control subjects) from two large independent Dutch cohorts and one Danish cohort. In addition, 340 Dutch subjects underwent a 2-h hyperglycaemic clamp to investigate insulin secretion. Since sexual dimorphic associations related to DRD2 polymorphisms have been previously reported, we also performed a gender-stratified analysis.RESULTS: rs1800497 at the DRD2/ANKK1 locus was associated with a significantly increased risk for Type 2 diabetes in women (odds ratio 1.14 (1.06-1.23); P = 4.1*10(-4) ) but not in men (odds ratio 1.00 (95% CI 0.93-1.07); P = 0.92) or the combined group. Although rs1800497 was not associated with insulin secretion, we did find another single nucleotide polymorphism in this locus, rs6275, to be associated with increased first-phase glucose-stimulated insulin secretion in women (P = 5.5*10(-4) ) but again not in men (P = 0.34).CONCLUSION: The present data identify DRD2/ANKK1 as a potential sex-specific Type 2 diabetes susceptibility gene.

AB - AIMS: Modulation of dopamine receptor D2 (DRD2) activity affects insulin secretion in both rodents and isolated pancreatic β-cells. We hypothesized that single nucleotide polymorphisms in the DRD2/ANKK1 locus may affect susceptibility to Type 2 diabetes in humans.METHODS: Four potentially functional variants in the coding region of the DRD2/ANKK1 locus (rs1079597, rs6275, rs6277, rs1800497) were genotyped and analysed for Type 2 diabetes susceptibility in up to 25 000 people (8148 with Type 2 diabetes and 17687 control subjects) from two large independent Dutch cohorts and one Danish cohort. In addition, 340 Dutch subjects underwent a 2-h hyperglycaemic clamp to investigate insulin secretion. Since sexual dimorphic associations related to DRD2 polymorphisms have been previously reported, we also performed a gender-stratified analysis.RESULTS: rs1800497 at the DRD2/ANKK1 locus was associated with a significantly increased risk for Type 2 diabetes in women (odds ratio 1.14 (1.06-1.23); P = 4.1*10(-4) ) but not in men (odds ratio 1.00 (95% CI 0.93-1.07); P = 0.92) or the combined group. Although rs1800497 was not associated with insulin secretion, we did find another single nucleotide polymorphism in this locus, rs6275, to be associated with increased first-phase glucose-stimulated insulin secretion in women (P = 5.5*10(-4) ) but again not in men (P = 0.34).CONCLUSION: The present data identify DRD2/ANKK1 as a potential sex-specific Type 2 diabetes susceptibility gene.

U2 - 10.1111/dme.12464

DO - 10.1111/dme.12464

M3 - Journal article

C2 - 24724616

VL - 31

SP - 1001

EP - 1008

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 8

ER -

ID: 120783562